Filter announcements
Loading...
Established in Hyderabad, India in 1978, Gland Pharma has grown over the years from a contract manufacturer of small volume liquid parenteral products, to become one of the largest and fastest growing injectable-focused companies, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India and other markets. We operate primarily under a business to business (B2B) model…
Gland Pharma has announced a board meeting to review its financial results for the quarter and nine months ended December 31, 2024. The company reported a total revenue from operations of ₹13,840.52 million and utilized expenses amounting to ₹11,432.44 million, leading to a profit before tax of ₹2,993.02 million. The...